Shifting from the single to the multitarget paradigm in drug discovery
Author:
Funder
NIDA
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference60 articles.
1. Einfluss der Configuration auf die Wirkung der Enzyme;Fischer;Ber. Dtsch. Chem. Ges.,1894
2. The reductionist paradox: are the laws of chemistry and physics sufficient for the discovery of new drugs?;Maggiora;J. Comput. Aided Mol. Des.,2011
3. Mixture-based synthetic combinatorial libraries;Houghten;J. Med. Chem.,1999
4. Visualization of the chemical space in drug discovery;Medina-Franco;Curr. Comput. Aided Drug Des.,2008
5. Open access high throughput drug discovery in the public domain: a Mount Everest in the making;Roy;Curr. Pharm. Biotechnol.,2010
Cited by 367 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition;European Journal of Medicinal Chemistry;2024-02
2. Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders;Neuron;2024-01
3. Network-Based Methods and Their Applications in Drug Discovery;Journal of Chemical Information and Modeling;2023-12-27
4. Ligand and Structure-Based Drug Design (LBDD and SBDD): Promising Approaches to Discover New Drugs;Applied Computer-Aided Drug Design: Models and Methods;2023-12-07
5. Structure, function and drug discovery of GPCR signaling;Molecular Biomedicine;2023-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3